Procter & Gamble Company (The) $PG Shares Bought by Financial Freedom LLC

Financial Freedom LLC boosted its stake in Procter & Gamble Company (The) (NYSE:PG) by 17.9% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 44,757 shares of the company’s stock after acquiring an additional 6,786 shares during the period. Procter & Gamble accounts for 3.0% of Financial Freedom LLC’s portfolio, making the stock its 9th biggest position. Financial Freedom LLC’s holdings in Procter & Gamble were worth $6,502,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in PG. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $26,000. Montgomery Financial Services LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at $28,000. Paladin Partners LLC acquired a new stake in shares of Procter & Gamble during the second quarter worth $29,000. Toews Corp ADV acquired a new stake in shares of Procter & Gamble during the second quarter worth $37,000. Finally, Evergreen Advisors LLC bought a new position in Procter & Gamble during the first quarter worth $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, CFO Andre Schulten sold 30,677 shares of the firm’s stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $169.00, for a total value of $5,184,413.00. Following the completion of the sale, the chief financial officer directly owned 65,618 shares in the company, valued at $11,089,442. This trade represents a 31.86% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Juliana Azevedo sold 5,370 shares of the business’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $169.00, for a total value of $907,530.00. Following the completion of the sale, the chief executive officer directly owned 21,361 shares of the company’s stock, valued at $3,610,009. The trade was a 20.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 200,006 shares of company stock worth $32,715,058 over the last 90 days. 0.23% of the stock is owned by company insiders.

Key Procter & Gamble News

Investors following PG have been watching these news items:

• Positive Sentiment: P&G’s latest quarter beat expectations: earnings were $2.00 per share versus $1.89 expected, and revenue was $23.28 billion versus $22.80 billion expected, up 4% year over year. The results have helped lift shares toward a 52-week high. Article: Procter & Gamble Has Raised Its Dividend for 70 Straight Years
• Neutral Sentiment: Recent valuation coverage asks whether P&G’s current market value is justified by its expected cash flows and how its valuation compares with rivals. This may make valuation more salient after the stock’s recent gains, but the available article summaries do not provide a specific fair-value estimate. Article: Is Procter & Gamble Stock Worth More Than Its Rivals?
• Negative Sentiment: CEO El Hak Hesham Abd sold 2,250 shares for about $379,000, reducing his direct ownership by 20.06% to 8,968 shares. The sale may draw attention, although a single transaction does not establish a change in the company’s outlook. SEC Form 4 filing

Procter & Gamble Stock Performance

NYSE:PG opened at $169.84 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $170.73. The company has a fifty day moving average of $154.26 and a 200-day moving average of $149.93. The firm has a market capitalization of $393.65 billion, a P/E ratio of 25.58, a P/E/G ratio of 4.13 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. Procter & Gamble’s revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.99 earnings per share. As a group, sell-side analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is 65.51%.

Analyst Ratings Changes

PG has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $162.00 to $180.00 and gave the company an “overweight” rating in a report on Friday, October 23rd. The Goldman Sachs Group reiterated a “neutral” rating and set a $161.00 price target on shares of Procter & Gamble in a report on Thursday, October 22nd. BNP Paribas Exane lifted their price objective on Procter & Gamble from $177.00 to $189.00 and gave the stock an “outperform” rating in a research report on Friday, October 23rd. Morgan Stanley lifted their price objective on Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a research report on Friday, October 23rd. Finally, Barclays boosted their price objective on Procter & Gamble from $152.00 to $165.00 and gave the company an “equal weight” rating in a research note on Monday, October 26th. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $170.57.

About Procter & Gamble

The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.